Rejuve is a new start up which aims to use blockchain technology for its exciting research. The company aims to substantially increase human health and life expectancy. These jobs are not new to the healthcare industry. In fact, many other companies are striving to achieve the same goal. After all, life is precious and we all want to enjoy it as much as possible. However, traditional companies often fall short of this mission. While human lifespans have lengthened considerably in recent decades, that has more to do with good medicines and health care systems, as well as organic food and better living conditions. Still, there are places around the world that are still suffering from economic crisis or devastated by wars. In such countries, people’s life expectancy is dramatically short.
Still, Rejuve wants to bring real innovation. Its goal is to help people live longer with or without the benefit of the highest quality food or medicine. If this company succeeds, it can revolutionize the world and change our lives.
The team will rely on Artificial Intelligence. It will create the first decentralized research network in the world that will work exclusively on longevity problems. The founders of the project believe that bringing together artificial intelligence, blockchain, and longevity-focused research will help them substantially increase the human health lifespan.
The company will incorporate advanced longevity therapies and test various solutions. In addition, it will make them available to people who want them. These therapies will be affordable for all clients. The team will also offer great rewards to people who contribute data and help with this research.
What is RJV and how does it work?
RJV is the company’s native utility token. The total amount of ERC20 tokens available is 1,000,000,000. The team intends to start their ICO sale in March. However, only 27.42% will be available for purchase at this stage. The platform will accept USDT in exchange for your tokens. RJV will grant its holders various benefits. Furthermore, the buyers will essentially become investors in this company.
Rejuve will add some other incentives to attract more investors. You believe that your project will be successful. Furthermore, his ultimate goal is not a utopia. Such practices already exist. However, they are now only available to very wealthy people.
The team believes that it must change. Average people also have the right to enjoy a longer life. According to the company, the data connected to these innovative technologies is already available to many people through frequent siphoning. However, keeping the information is not enough to use it successfully. Therefore, even those people who get it have almost no benefit.
On the other hand, Rejuve will allow clients to receive real results. In addition, the company will use a unique tokenomic model to incentivize users to participate in its therapies and thus support research.
What about the market?
The company will offer its own product similar to SingularityNET. The team plans to create a decentralized marketplace specifically for AI. Also, it will provide a great ecosystem.
In 2018, SingularityNET incubated this project. It now functions as a conduit for Rejuve’s Bio-AI research. The team stated that Longevity is actually a natural match for AI and Futurism. Therefore, many users with an affinity for technology will find that modern technology can be of great help in learning how to gain more years of life.
Additionally, Rejuve is currently working on a research database that will be active and interactive. The company plans to leverage data from partners and members of the network. It will also reward all participants. The team noted that live, the RJV token is a form of reward. But there will be others, too.
The company also created its main data collection tool. The last one is the mobile app called – Longevity. It will be available on iOS and Android systems. This application will allow customers to upload their personal health data and share it with the company. That could include various surveys and lab tests. In exchange, users will receive RJV tokens, while the company will use that data to further its research and get real results.
According to Rejuve, the user’s account will be like an electronic personal health record. It will allow the company and associated laboratories to continue research based on various metrics.
!function (f, b, e, v, n, t, s) {
if (f.fbq) return;
n = f.fbq = function () {
n.callMethod ?
n.callMethod.apply(n, arguments) : n.queue.push(arguments)
};
if (!f._fbq) f._fbq = n;
n.push = n;
n.loaded = !0;
n.version = ‘2.0’;
n.queue = ();
t = b.createElement(e);
t.async = !0;
t.src = v;
s = b.getElementsByTagName(e)(0);
s.parentNode.insertBefore(t, s)
}(window, document, ‘script’,
‘https://connect.facebook.net/en_US/fbevents.js’);
fbq(‘init’, ‘504526293689977’);
fbq(‘track’, ‘PageView’);
